Sign in

Constellation Brands, Inc. STZ

Price 129.1 USD
as of 2026-09-05
56/100
Mixed
Quality71
Growth52
Balance-sheet strength46
Valuation71
Momentum25
Income77

Composite 56/100; the shares have moved about 30% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 25/100 — a moderate mark against it.

Case for

Income ranks 77/100 — a strong point in its favour. Valuation ranks 71/100 — a moderate point in its favour. Quality ranks 71/100 — a moderate point in its favour.

Case against

Momentum ranks 25/100 — a moderate mark against it. Balance-sheet strength ranks 46/100 — a slight mark against it.

What the company does Constellation Brands (STZ) is a leading producer and marketer of beer, wine, and spirits under brands like Corona, Modelo, and The Prisoner Wine Company, distributing primarily in the U.S. and internationally.

Key financials The company shows strong profitability with ROE 23.7%, ROA 8.6%, and net margins 20.1%. Revenue declined -10.5% while EPS grew 30.7%, supported by high gross margins 52.7%. Debt/Equity is 1.23 with interest coverage 8.42, and it yields 3.2% with a 34.1% payout ratio.

Stock health SideraVIA scores highlight strong quality (71.1) and income (74.5) but weak momentum (25.2). Profitability metrics like Piotroski F-Score 7/9 and Altman Z 2.75 indicate resilience, though current ratio is 0.91.

Price vs fair value STZ trades at a discount of 30.70% versus the analyst mean target of 170.83. - Recent headlines question beer stock valuations (Barrons.com) - Supply chain leadership changes noted (Supply Chain Dive) - Investment in U.S. farm profitability announced (Food Dive) - Hard seltzer brand PRESS sold (Milwaukee Journal Sentinel)

Looking forward Forward P/E of 11.36 and PEG of 0.93 suggest attractive valuation, but weak momentum and sector skepticism may cap near-term gains. Focus remains on execution in supply chain and brand strength.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.